An autoimmune drug that failed in a previous clinical trial to improve conditions for patients with severe Covid-19 has shown efficacy in a second study....
A major European pharmaceutical company has signed on to distribute an antibody drug under development for Covid-19 outside the U.S. Tarrytown, New York-based Regeneron Pharmaceuticals...
The Food and Drug Administration has approved a drug for treating a rare autoimmune disorder that can cause blindness, muscle weakness and paralysis. Basel, Switzerland-based...
The Food and Drug Administration has approved the latest entrant into the market for drugs to treat spinal muscular atrophy. South Plainfield, New Jersey-based PTC...
Results of a trial of an anti-inflammatory drug from Swiss pharmaceutical giant Roche in patients with Covid-19 have shown the drug to be ineffective, the...
Swiss drugmaker Roche and its U.S. subsidiary are working with a startup focused on real-world data to use patient data to advance research in multiple...
Swiss drugmaker Roche has signed an agreement potentially worth more than $1.7 billion focused on an investigational drug designed to treat cancers by targeting genetic...